122 related articles for article (PubMed ID: 37702691)
1. Decrease of lncRNA MEG3 in Acute Myeloid Leukemia Affected the Expression of p53 and MDM2.
Jia Y; He E; Peng J; Zhao M
Clin Lab; 2023 Sep; 69(9):. PubMed ID: 37702691
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression.
Lu KH; Li W; Liu XH; Sun M; Zhang ML; Wu WQ; Xie WP; Hou YY
BMC Cancer; 2013 Oct; 13():461. PubMed ID: 24098911
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA MEG3 inhibits proliferation of chronic myeloid leukemia cells by sponging microRNA21.
Li Z; Yang L; Liu X; Nie Z; Luo J
Biomed Pharmacother; 2018 Aug; 104():181-192. PubMed ID: 29772439
[TBL] [Abstract][Full Text] [Related]
4. LncRNA Meg3 protects endothelial function by regulating the DNA damage response.
Shihabudeen Haider Ali MS; Cheng X; Moran M; Haemmig S; Naldrett MJ; Alvarez S; Feinberg MW; Sun X
Nucleic Acids Res; 2019 Feb; 47(3):1505-1522. PubMed ID: 30476192
[TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor protects bone marrow mesenchymal stem cells from hypoxia/ischemia-induced apoptosis by regulating lncRNA MEG3.
Bai Z; Hu K; Yu J; Shen Y; Chen C
J Zhejiang Univ Sci B; 2022 Dec; 23(12):989-1001. PubMed ID: 36518052
[TBL] [Abstract][Full Text] [Related]
6. Dysfunction of the WT1-MEG3 signaling promotes AML leukemogenesis via p53-dependent and -independent pathways.
Lyu Y; Lou J; Yang Y; Feng J; Hao Y; Huang S; Yin L; Xu J; Huang D; Ma B; Zou D; Wang Y; Zhang Y; Zhang B; Chen P; Yu K; Lam EW; Wang X; Liu Q; Yan J; Jin B
Leukemia; 2017 Dec; 31(12):2543-2551. PubMed ID: 28400619
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA MEG3 knockdown attenuates endoplasmic reticulum stress-mediated apoptosis by targeting p53 following myocardial infarction.
Li X; Zhao J; Geng J; Chen F; Wei Z; Liu C; Zhang X; Li Q; Zhang J; Gao L; Xie J; Xu B
J Cell Mol Med; 2019 Dec; 23(12):8369-8380. PubMed ID: 31631486
[TBL] [Abstract][Full Text] [Related]
8. LncRNA MEG3 contributes to drug resistance in acute myeloid leukemia by positively regulating ALG9 through sponging miR-155.
Yu Y; Kou D; Liu B; Huang Y; Li S; Qi Y; Guo Y; Huang T; Qi X; Jia L
Int J Lab Hematol; 2020 Aug; 42(4):464-472. PubMed ID: 32359033
[TBL] [Abstract][Full Text] [Related]
9. TET2 and MEG3 promoter methylation is associated with acute myeloid leukemia in a Hainan population.
Yao H; Duan M; Lin L; Wu C; Fu X; Wang H; Guo L; Chen W; Huang L; Liu D; Rao R; Wang S; Ding Y
Oncotarget; 2017 Mar; 8(11):18337-18347. PubMed ID: 28407691
[TBL] [Abstract][Full Text] [Related]
10. Long Non-Coding RNA MEG3 Downregulation Triggers Human Pulmonary Artery Smooth Muscle Cell Proliferation and Migration via the p53 Signaling Pathway.
Sun Z; Nie X; Sun S; Dong S; Yuan C; Li Y; Xiao B; Jie D; Liu Y
Cell Physiol Biochem; 2017; 42(6):2569-2581. PubMed ID: 28848087
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of LncRNA MEG3 inhibits cell migration and invasion and enhances cisplatin chemosensitivity in bladder cancer cells.
Feng SQ; Zhang XY; Fan HT; Sun QJ; Zhang M
Neoplasma; 2018 Nov; 65(6):925-932. PubMed ID: 29940769
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA MEG3 is a tumor suppressor in choriocarcinoma by upregulation of microRNA-211.
Ji L; Li X
J Cell Physiol; 2019 Dec; 234(12):22911-22920. PubMed ID: 31124134
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA MEG3 mediated angiogenesis after cerebral infarction through regulating p53/NOX4 axis.
Zhan R; Xu K; Pan J; Xu Q; Xu S; Shen J
Biochem Biophys Res Commun; 2017 Aug; 490(3):700-706. PubMed ID: 28634073
[TBL] [Abstract][Full Text] [Related]
14. Tumor-suppressive MEG3 induces microRNA-493-5p expression to reduce arabinocytosine chemoresistance of acute myeloid leukemia cells by downregulating the METTL3/MYC axis.
Wang A; Chen Y; Shi L; Li M; Li L; Wang S; Wang C
J Transl Med; 2022 Jun; 20(1):288. PubMed ID: 35761379
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of long noncoding RNA maternally expressed gene 3 in acute promyelocytic leukemia.
Jiang M; Wang Q; Yu G; Wan J; Liu S; Zhang Z; Le A
Int J Lab Hematol; 2021 Aug; 43(4):693-698. PubMed ID: 33372415
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA taurine-upregulated gene 1 correlates with poor prognosis, induces cell proliferation, and represses cell apoptosis via targeting aurora kinase A in adult acute myeloid leukemia.
Wang X; Zhang L; Zhao F; Xu R; Jiang J; Zhang C; Liu H; Huang H
Ann Hematol; 2018 Aug; 97(8):1375-1389. PubMed ID: 29654398
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of lncRNA MEG3 attenuates high glucose-induced cardiomyocytes injury by inhibiting mitochondria-mediated apoptosis pathway.
Zhang WW; Geng X; Zhang WQ
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7599-7604. PubMed ID: 31539151
[TBL] [Abstract][Full Text] [Related]
18. Superior anti-tumor activity of the MDM2 antagonist idasanutlin and the Bcl-2 inhibitor venetoclax in p53 wild-type acute myeloid leukemia models.
Lehmann C; Friess T; Birzele F; Kiialainen A; Dangl M
J Hematol Oncol; 2016 Jun; 9(1):50. PubMed ID: 27353420
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic silencing of ZCCHC10 by the lncRNA SNHG1 promotes progression and venetoclax resistance of acute myeloid leukemia.
Zhou H; Zhang Q; Huang W; He C; Zhou C; Zhou J; Ning Y
Int J Oncol; 2023 May; 62(5):. PubMed ID: 37052262
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA MEG3 inhibits breast cancer growth via upregulating endoplasmic reticulum stress and activating NF-κB and p53.
Zhang Y; Wu J; Jing H; Huang G; Sun Z; Xu S
J Cell Biochem; 2019 Apr; 120(4):6789-6797. PubMed ID: 30556250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
